These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15989462)

  • 21. Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals.
    Hassaïne G; Agostini I; Candotti D; Bessou G; Caballero M; Agut H; Autran B; Barthalay Y; Vigne R
    Virology; 2000 Oct; 276(1):169-80. PubMed ID: 11022005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
    Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
    J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.
    Goncalves J; Shi B; Yang X; Gabuzda D
    J Virol; 1995 Nov; 69(11):7196-204. PubMed ID: 7474141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservation of amino-acid sequence motifs in lentivirus Vif proteins.
    Oberste MS; Gonda MA
    Virus Genes; 1992 Jan; 6(1):95-102. PubMed ID: 1312756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.
    Karczewski MK; Strebel K
    J Virol; 1996 Jan; 70(1):494-507. PubMed ID: 8523563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.
    Gaddis NC; Chertova E; Sheehy AM; Henderson LE; Malim MH
    J Virol; 2003 May; 77(10):5810-20. PubMed ID: 12719574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementation of human immunodeficiency virus type 1 vif mutants in some CD4+ T-cell lines.
    Hevey M; Donehower LA
    Virus Res; 1994 Sep; 33(3):269-80. PubMed ID: 7527173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feline immunodeficiency virus Vif localizes to the nucleus.
    Chatterji U; Grant CK; Elder JH
    J Virol; 2000 Mar; 74(6):2533-40. PubMed ID: 10684267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.
    Yang B; Gao L; Li L; Lu Z; Fan X; Patel CA; Pomerantz RJ; DuBois GC; Zhang H
    J Biol Chem; 2003 Feb; 278(8):6596-602. PubMed ID: 12480936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.
    Gabuzda DH; Lawrence K; Langhoff E; Terwilliger E; Dorfman T; Haseltine WA; Sodroski J
    J Virol; 1992 Nov; 66(11):6489-95. PubMed ID: 1357189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.
    Kao S; Akari H; Khan MA; Dettenhofer M; Yu XF; Strebel K
    J Virol; 2003 Jan; 77(2):1131-40. PubMed ID: 12502829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.
    Sakai K; Ma XY; Gordienko I; Volsky DJ
    J Virol; 1991 Nov; 65(11):5765-73. PubMed ID: 1920615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.
    Madani N; Millette R; Platt EJ; Marin M; Kozak SL; Bloch DB; Kabat D
    J Virol; 2002 Nov; 76(21):11133-8. PubMed ID: 12368356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apparent lack of trans-dominant negative effects of various vif mutants on the replication of HIV-1.
    Fujita M; Matsumoto S; Sakurai A; Doi N; Miyaura M; Yoshida A; Adachi A
    Microbes Infect; 2002 Oct; 4(12):1203-7. PubMed ID: 12467760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the structural understanding of Vif proteins.
    Barraud P; Paillart JC; Marquet R; Tisné C
    Curr HIV Res; 2008 Mar; 6(2):91-9. PubMed ID: 18336256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Vif protein of human immunodeficiency virus type 1 (HIV-1): enigmas and solutions.
    Baraz L; Kotler M
    Curr Med Chem; 2004 Jan; 11(2):221-31. PubMed ID: 14754418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein.
    Yang X; Gabuzda D
    J Biol Chem; 1998 Nov; 273(45):29879-87. PubMed ID: 9792705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants.
    Reddy TR; Kraus G; Yamada O; Looney DJ; Suhasini M; Wong-Staal F
    J Virol; 1995 Jun; 69(6):3549-53. PubMed ID: 7745702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a functionally important amino acid residue near to the amino-terminus of the human immunodeficiency virus type 1 Vif protein.
    Boyce M; Willingmann P; McCrae M
    Virus Genes; 1999; 19(1):15-22. PubMed ID: 10499446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtle mutations in the cysteine region of HIV-1 Vif drastically alter the viral replication phenotype.
    Fujita M; Sakurai A; Yoshida A; Matsumoto S; Miyaura M; Adachi A
    Microbes Infect; 2002 May; 4(6):621-4. PubMed ID: 12048031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.